Gary Gilkeson to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications Gary Gilkeson has written about Hematopoietic Stem Cell Transplantation.
Connection Strength
1.293
-
Safety and Efficacy of Mesenchymal Stromal Cells and Other Cellular Therapeutics in Rheumatic Diseases in 2022: A Review of What We Know So Far. Arthritis Rheumatol. 2022 05; 74(5):752-765.
Score: 0.681
-
Hematopoetic and mesenchymal stem cell transplantation in the treatment of refractory systemic lupus erythematosus--where are we now? Clin Immunol. 2013 Sep; 148(3):328-34.
Score: 0.361
-
New therapies and preventive strategies to treat and minimize damage in lupus. Curr Rheumatol Rep. 2005 Dec; 7(6):457-62.
Score: 0.220
-
A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus. Stem Cell Reports. 2018 03 13; 10(3):933-941.
Score: 0.032